Parker Geoffrey M.

CHIEF FINANCIAL OFFICER at Allogene Therapeutics, Inc. · on record since Oct 17, 2023
Director at GENOPTIX INC · on record since Jun 3, 2010
Director at ChemoCentryx, Inc. · on record since Feb 13, 2012
Director at PERRIGO Co plc · on record since May 15, 2026
Executive Vice President & CFO at Anacor Pharmaceuticals, Inc. · on record since May 30, 2014
Director at Viracta Therapeutics, Inc. · on record since May 27, 2016
Director at GENOMIC HEALTH INC · on record since Jun 23, 2016
COO, CFO and EVP at Tricida, Inc. · on record since Jun 27, 2018
Director at Better Therapeutics, Inc. · on record since Dec 16, 2021

Insider trading activity of Parker Geoffrey M.

Transactions on record: 249; since Jun 3, 2010

Open-market buys: 75; $9.1M

Open-market sells: 13; $3.3M

Companies traded: 9; last filing Sep 15, 2026

Figures computed from official regulatory filings — .

Companies where Parker Geoffrey M. has traded

PERRIGO Co plc66 tx · $5.1M · Sep 15, 2026
Allogene Therapeutics, Inc.15 tx · $1.2M · Feb 4, 2026
Better Therapeutics, Inc.10 tx · $918.9K · Dec 20, 2023
ChemoCentryx, Inc.67 tx · $4.2M · Oct 24, 2022
Tricida, Inc.26 tx · $6.1M · Mar 2, 2022
GENOMIC HEALTH INC10 tx · Nov 14, 2019
9 tx · $58.3K · Jun 2, 2017
41 tx · $2.5M · Mar 23, 2015
5 tx · $18.3K · Mar 1, 2011

Track record of Parker Geoffrey M.

Statistical track record

Free account

Open-market buys: 75

Last buy: Nov 12, 2025

Win rates, median returns and the proven-insider analysis come with a free account.

Transaction history of Parker Geoffrey M.

Co-insiders of Parker Geoffrey M.

This page republishes public regulatory disclosures.

Company	Filed	Type	Qty	Price	Value · USD	Signals	Src
PERRIGO Co plcListing on record	Sep 15, 2026	Exercise	1,263	13.66 USD	$17.3K		SEC
PERRIGO Co plcListing on record	Sep 15, 2026	ExerciseD (derivative)	-1,263	—	n/a (No price was disclosed in the filing)		SEC
PERRIGO Co plcListing on record	Sep 15, 2026	Other	-607	13.66 USD	$8.3K		SEC
PERRIGO Co plcListing on record	Jun 16, 2026	AwardD (derivative)	844	—	n/a (No price was disclosed in the filing)		SEC
PERRIGO Co plcListing on record	Jun 16, 2026	ExerciseD (derivative)	-976	—	n/a (No price was disclosed in the filing)		SEC
PERRIGO Co plcListing on record	Jun 16, 2026	Other	-469	10.99 USD	$5.2K		SEC
PERRIGO Co plcListing on record	Jun 16, 2026	Exercise	976	10.99 USD	$10.7K		SEC
PERRIGO Co plcListing on record	May 15, 2026	AwardD (derivative)	16,681	—	n/a (No price was disclosed in the filing)		SEC
PERRIGO Co plcListing on record	May 15, 2026	Exercise	7,305	10.84 USD	$79.2K		SEC
PERRIGO Co plcListing on record	May 15, 2026	ExerciseD (derivative)	-7,305	—	n/a (No price was disclosed in the filing)		SEC
PERRIGO Co plcListing on record	May 15, 2026	Other	-3,507	10.84 USD	$38K		SEC
PERRIGO Co plcListing on record	Mar 17, 2026	AwardD (derivative)	3,024	—	n/a (No price was disclosed in the filing)		SEC
Allogene Therapeutics, Inc.Listing on record	Feb 4, 2026	AwardD (derivative)	539,072	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Allogene Therapeutics, Inc.Listing on record	Feb 4, 2026	AwardD (derivative)	152,480	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Allogene Therapeutics, Inc.Listing on record	Feb 4, 2026	Sell	-24,001	1.76 USD	$42.2K		SEC
PERRIGO Co plcListing on record	Dec 16, 2025	AwardD (derivative)	2,140	—	n/a (No price was disclosed in the filing)		SEC
PERRIGO Co plcListing on record	Nov 14, 2025	Buy	7,500	14.18 USD	$106.4K	conv 59Cluster	SEC
Allogene Therapeutics, Inc.Listing on record	Oct 23, 2025	Sell	-36,744	1.26 USD	$46.3K		SEC
PERRIGO Co plcListing on record	Sep 16, 2025	AwardD (derivative)	1,263	—	n/a (No price was disclosed in the filing)		SEC
PERRIGO Co plcListing on record	Aug 20, 2025	Buy	4,375	22.97 USD	$100.5K	conv 55Cluster	SEC
PERRIGO Co plcListing on record	Aug 19, 2025	Buy	4,375	22.97 USD	$100.5K	conv 42Cluster	SEC
PERRIGO Co plcListing on record	Jun 17, 2025	AwardD (derivative)	976	—	n/a (No price was disclosed in the filing)		SEC
PERRIGO Co plcListing on record	May 16, 2025	Exercise	9,904	26.01 USD	$257.6K		SEC
PERRIGO Co plcListing on record	May 16, 2025	AwardD (derivative)	7,305	—	n/a (No price was disclosed in the filing)		SEC
PERRIGO Co plcListing on record	May 16, 2025	Other	-4,754	26.01 USD	$123.7K		SEC

Company	Filed	Type	Qty	Price	Value · USD	Signals	Src
PERRIGO Co plcListing on record	Sep 15, 2026	Exercise	1,263	13.66 USD	$17.3K		SEC
PERRIGO Co plcListing on record	Sep 15, 2026	ExerciseD (derivative)	-1,263	—	n/a (No price was disclosed in the filing)		SEC
PERRIGO Co plcListing on record	Sep 15, 2026	Other	-607	13.66 USD	$8.3K		SEC
PERRIGO Co plcListing on record	Jun 16, 2026	AwardD (derivative)	844	—	n/a (No price was disclosed in the filing)		SEC
PERRIGO Co plcListing on record	Jun 16, 2026	ExerciseD (derivative)	-976	—	n/a (No price was disclosed in the filing)		SEC
PERRIGO Co plcListing on record	Jun 16, 2026	Other	-469	10.99 USD	$5.2K		SEC
PERRIGO Co plcListing on record	Jun 16, 2026	Exercise	976	10.99 USD	$10.7K		SEC
PERRIGO Co plcListing on record	May 15, 2026	AwardD (derivative)	16,681	—	n/a (No price was disclosed in the filing)		SEC
PERRIGO Co plcListing on record	May 15, 2026	Exercise	7,305	10.84 USD	$79.2K		SEC
PERRIGO Co plcListing on record	May 15, 2026	ExerciseD (derivative)	-7,305	—	n/a (No price was disclosed in the filing)		SEC
PERRIGO Co plcListing on record	May 15, 2026	Other	-3,507	10.84 USD	$38K		SEC
PERRIGO Co plcListing on record	Mar 17, 2026	AwardD (derivative)	3,024	—	n/a (No price was disclosed in the filing)		SEC
Allogene Therapeutics, Inc.Listing on record	Feb 4, 2026	AwardD (derivative)	539,072	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Allogene Therapeutics, Inc.Listing on record	Feb 4, 2026	AwardD (derivative)	152,480	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Allogene Therapeutics, Inc.Listing on record	Feb 4, 2026	Sell	-24,001	1.76 USD	$42.2K		SEC
PERRIGO Co plcListing on record	Dec 16, 2025	AwardD (derivative)	2,140	—	n/a (No price was disclosed in the filing)		SEC
PERRIGO Co plcListing on record	Nov 14, 2025	Buy	7,500	14.18 USD	$106.4K	conv 59Cluster	SEC
Allogene Therapeutics, Inc.Listing on record	Oct 23, 2025	Sell	-36,744	1.26 USD	$46.3K		SEC
PERRIGO Co plcListing on record	Sep 16, 2025	AwardD (derivative)	1,263	—	n/a (No price was disclosed in the filing)		SEC
PERRIGO Co plcListing on record	Aug 20, 2025	Buy	4,375	22.97 USD	$100.5K	conv 55Cluster	SEC
PERRIGO Co plcListing on record	Aug 19, 2025	Buy	4,375	22.97 USD	$100.5K	conv 42Cluster	SEC
PERRIGO Co plcListing on record	Jun 17, 2025	AwardD (derivative)	976	—	n/a (No price was disclosed in the filing)		SEC
PERRIGO Co plcListing on record	May 16, 2025	Exercise	9,904	26.01 USD	$257.6K		SEC
PERRIGO Co plcListing on record	May 16, 2025	AwardD (derivative)	7,305	—	n/a (No price was disclosed in the filing)		SEC
PERRIGO Co plcListing on record	May 16, 2025	Other	-4,754	26.01 USD	$123.7K		SEC